<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Antibiotic synergy &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/antibiotic-synergy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Thu, 08 Oct 2026 16:45:37 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Antibiotic synergy &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Ancient Skullcap Flavonoid Supercharges Last-Resort Antibiotic Against Deadly Hospital Superbug</title>
		<link>https://bioengineer.org/ancient-skullcap-flavonoid-supercharges-last-resort-antibiotic-against-deadly-hospital-superbug/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Thu, 08 Oct 2026 16:45:37 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Acinetobacter baumannii]]></category>
		<category><![CDATA[Antibiotic synergy]]></category>
		<category><![CDATA[antimicrobial adjuvants]]></category>
		<category><![CDATA[baicalein]]></category>
		<category><![CDATA[Biofilm inhibition]]></category>
		<category><![CDATA[Carbapenem resistance]]></category>
		<category><![CDATA[ceftazidime-avibactam]]></category>
		<category><![CDATA[efflux pumps]]></category>
		<category><![CDATA[hospital-acquired infection]]></category>
		<category><![CDATA[iron homeostasis]]></category>
		<category><![CDATA[small regulatory RNA]]></category>
		<category><![CDATA[Transcriptomics]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=407874</guid>

					<description><![CDATA[A new in vitro study shows that baicalein, a flavonoid from Scutellaria baicalensis, synergizes with ceftazidime-avibactam to kill carbapenem-resistant Acinetobacter baumannii by modulating efflux pumps, iron homeostasis, and key metabolic pathways.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">407874</post-id>	</item>
		<item>
		<title>Optimized THPA Dipeptides Combat Methicillin-Resistant Staphylococcus Aureus</title>
		<link>https://bioengineer.org/optimized-thpa-dipeptides-combat-methicillin-resistant-staphylococcus-aureus/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 10 Nov 2025 12:59:35 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Antibiotic synergy]]></category>
		<category><![CDATA[İşte 5 uygun etiket: **THPA conjugated peptides]]></category>
		<category><![CDATA[MRSA treatment]]></category>
		<category><![CDATA[Peptide mechanism]]></category>
		<guid isPermaLink="false">https://bioengineer.org/optimized-thpa-dipeptides-combat-methicillin-resistant-staphylococcus-aureus/</guid>

					<description><![CDATA[In the relentless battle against antimicrobial resistance, the spotlight increasingly falls on Methicillin-resistant Staphylococcus aureus (MRSA), a pathogen that has long evaded conventional treatments. Researchers have rigorously explored new avenues to address this global health crisis, where standard antibiotics often fall short. Recent studies have unveiled promising candidates in the form of short cationic antimicrobial [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">294032</post-id>	</item>
	</channel>
</rss>
